investor.illumina.comIllumina, Inc. - Investors

Go to illumina.com Investing in the future of health Investors Overview Events & Presentations Stock Information Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Quarterly Results SEC Filings ESG GRAIL Acquisition Governance Resources Investor FAQs Investor Kit Investor Email Alerts Investor Contacts Delivering Value to Investors A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome. That mission is behind everything we do, from enabling breakthroughs that move us closer to the realization of precision medicine to delivering value to our investors. Investor Events View All Events & Presentations Press Releases View All Press Releases Stock Information View current and historic stock prices, analyst information, and more Financial Information Download quarterly earnings reports, supplementary data, SEC filings, and more Corporate Governance Learn about our governance guidelines, code of ethics, Board of Directors, and more Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. * Required Mailing Lists * Press Releases Events Presentations SEC Filings End of Day Stock Quote Email Address * Email Alert Sign Up Confirmation Contact Us General Inquiries Salli Schwartz, Vice President lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122 858.291.6421 [email protected] Transfer Agent Computershare Trust Company, N.A. Courier Delivery: P.O. Box 43006 Providence RI 02940-3006 Overnight Delivery: 150 Royall St. STE 101 Canton, MA 02021 877.373.6374 www.computershare.com Tools & Links Email Alerts Latest PresentationSEC Filings CSR Report Q1’21 Earnings ResultsInnovative technologies At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. For Research Use Only. Not for use in diagnostic procedures (except as specifically noted). © Illumina, Inc. All rights reserved. All trademarks are the property of Illumina, Inc. or their respective owners. For specific trademark information, see www.illumina.com/company/legal.html .Powered By Q4 Inc. 5.122.0.3 (opens in new...